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Abstract 
Inflammation is the ultimate response to the constant challenges of the immune system by 
microbes, irritants or injury. The inflammatory cascade initiates with the recognition of 
microorganism-derived pathogen associated molecular patterns (PAMPs) and host cell-derived 
damage associated molecular patterns (DAMPs) by the pattern recognition receptors (PRRs). DNA as 
a molecular PAMP or DAMP is sensed directly or via specific binding proteins to instigate pro-
inflammatory response. Some of these DNA binding proteins also participate in canonical DNA repair 
pathways and recognise damaged DNA to initiate DNA damage response.  In this review we aim to 
capture the essence of the complex interplay between DNA damage response and the pro-
inflammatory signalling through representative examples. 
1. Aetiology and molecular consequences of inflammation 
Inflammation, from the latin inflammare: set on fire, in mammals is the natural defence mechanism 
of the immune system in response to the constant challenges it is exposed to including injury, toxins 
and microorganisms, low level cosmic or medical quality radiations (X-ray, -irradiation or UVA/B), 
drugs and air pollutants (e.g. asbestos or cigarette smoke) 1,2*. Inflammation is a hallmark of aging 
and many chronic diseases such as obesity, Chron’s disease, Parkinson’s disease and autoimmune 
diseases just to name a few 3-7.  
 
 
 
*Additional on-line references are marked by superscript numbers 
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The first phase of a complex defence mechanism is acute inflammation instigated by the infiltrated 
peripheral polymorphonuclear leukocytes (neutrophils), granulocytes (eosinophils) and tissue 
resident phagocytes (macrophages) at the site of insult. The pro-inflammatory signal is transmitted 
through the PRRs that can identify danger through DAMPs (e.g. ROS, circulating DNA fragments), 
cytokines or chemokines released by the damaged tissue or PAMPs from pathogens [1] 8. The initial 
role of these cells is to remove the invading pathogen and initiate tissue repair 9.   
One of the major defence mechanisms of the activated neutrophils and macrophages is the 
production of a vast spectrum of endogenous reactive oxygen (ROS) and nitrogen (RNS) species 10 in 
a process termed “respiratory burst” 11 (see below). However, ROS, as well as the more stable and 
less reactive by-product of ROS production, hydrogen-peroxide (H2O2), are more than toxic products 
of respiratory burst, they are also effectors for a plethora of signalling pathways inducing innate and 
adaptive immune cell recruitment, proliferation, tissue healing, cell survival or apoptosis 12-14. As a 
secondary messenger ROS are essential contributors to the signalling cascade of receptors (e.g. 
members of the Toll-like [TLRs] or Nucleotide-binding oligomerisation domain [NOD]-like receptors 
[NLRs]) that induce pro-inflammatory innate immune response via an array of functionally diverse 
down-stream signalling elements (e.g. NFB, STAT1, IRF3 and caspase-1 activation) [2] 15-20. 
Inflammation is self-limiting and normally subsides following the removal of the insulting particles 
and completion of tissue repair. However, if the loss of tissue homeostasis is prolonged it may 
ultimately lead to chronic inflammation with increased recruitment of macrophages, enhanced 
senescence and suspended apoptosis, unregulated growth and tissue repair. The overwhelming 
persisting ROS production by inflammatory cells damages macromolecules (DNA, as well as RNA, 
lipids, carbohydrates and proteins) of the host cells 21,22 inducing genomic instability and tipping the 
balance of the antitumour activity of ROS to a tumour promoting one. Chronic inflammation is 
viewed as a susceptibility factor for many chronic diseases including asthma, cardiovascular, 
autoimmune, neurodegenerative and age-related disorders 23-30 and cancer 31-33.Oxidative burst-
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produced inflammatory ROS damage both nuclear (nuDNA) and mitochondrial (mtDNA) DNA causing 
genome instability and loss of homeostasis. Mammalian cells and the immune system have evolved 
an arsenal of receptors recognising molecules of pathogen- or host-origin, including DNA. Damaged 
host DNA, similar to bacterial DNA, signals danger and induces a wealth of signalling pathways to 
induce DNA damage response, DNA repair, inflammatory and immune response or cell death to 
restore tissue homeostasis and maintain host genomic integrity and survival. 
1.1 Generation of inflammation-induced ROS and RNS  
The chemical components of inflammatory response are ROS and RNS, molecules with free radicals 
(containing one unpaired electron) or other non-radical oxidants generated from oxygen or nitrogen 
14. Oxidative stress mediating ROS can typically arise from exogenous sources such as UVA or  -
irradiation, drugs, heavy metals 34-36, or from endogenous sources  e.g. oxidative metabolism, 
apoptosis, bystander cells or enzymatic activity 31,37-39. Extracellular ROS and RNS are produced by 
migrating neutrophils and macrophages at the site of injury or inflammation, while the intracellular 
sources are mostly biochemical processes through enzymatic reactions or autooxidation related to 
oxidative metabolism 40. An array of oxidants is generated by neutrophils and macrophages at the 
site of infection including superoxide (O2*
-), H2O2, hypochlorous acid (HOCl), nitric oxide (NO*) and 
nitrogen dioxide radicals (NO2*). These reactive species mostly arise from the enzymatic action of 
NADPH oxidases (NOXs), SOD, MPO and nitric oxide synthase (NOS) or non-enzymatic homolytic 
scissions, respectively.  
Upon activation of neutrophils and macrophages, membrane bound NADPH oxidases (NOXs) are 
assembled in the phagosomal, endosomal or cellular membrane (NOX2) [3] 41, or in the 
mitochondrial membrane (Complex I and III in the mitochondrial respiratory chain). NOXs catalyse 
the conversion of NADPH to NADP+ while leaking one electron that can be captured by dissolved O2 
to produce O2*
-, which is subsequently converted to additional anti-microbial and cytotoxic ROS. The 
O2*
- is released to the cytosol or the extracellular milieu where it is protonated to H2O2 and O2 by 
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superoxide dismutase (SOD) 42,43. H2O2 diffuses within the cell and through the aquaporins crosses 
the membrane into the extracellular space. Outside the cells it can travel long distances, which 
makes it a distant effector of phagocytic cellular killing 44. Hence, it is also recognised as a distant 
effector of phagocytes when transformed to more potent oxidising radicals by myeloperoxidase 
(MPO) 45,46. H2O2 is the substrate of MPO producing HOCl in neutrophils [4] 
47, or HOBr in eosinophils 
[5]. H2O2 is highly stable and less electrophilic in vivo, however, is also a source of more reactive 
hydroxyl radicals (OH*) when it is reduced in the Fenton reaction by ferrous or copper ions 14,48,49. 
The enzyme responsible for NO* production in macrophages and less abundantly in neutrophils is 
inducible nitric oxide synthase (iNOS) or i-mtNOS in the mitochondria [6] 50. Electron leaking from 
NADPH via NOS-mediated oxidation of L-arginine can also produce O2*
-. The reaction of NO* with 
O2*
- generates peroxynitrite (ONOO-). ONOO- is highly unstable and quickly autooxidates to nitrous 
anhydrate (N2O3) or converted to OH* and NO2*. NO2* and carbonate radical anion (CO3*
-) are the 
by-products of the reaction of ONOO- with CO2 followed by homolysis. Neutrophils also contribute to 
the NO2* pool via MPO-mediated reduction of nitrite (NO
2-) to NO2* [7] 
46,51,52. 
Under non-inflammatory conditions, low level ROS are intracellular signal transducers contributing 
to physiological activation of adaptive mechanisms maintaining cellular homeostasis. Low 
concentration of NO* has been observed to promote cell survival and proliferation, while non-
physiological levels can induce DNA damage, cell cycle arrest and apoptosis 53. Controlling non-
activated cellular ROS levels within physiological range is the delicate balance of the catalytic and 
scavenger action of a wealth of enzymatic and non-enzymatic (small molecule antioxidants) 
reactions. Enzymes catalysing ROS metabolism include SOD, catalases, glutathione peroxydases, and 
thioredoxin, glutathione, methionine sulphoxide or peroxinitrite reductases 54-57, while ascorbate, 
oxaloacetate and pyruvate are a few examples of small molecule antioxidants 13,58,59. 
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1.2 Mutator ROS: ROS-induced DNA damage and repair  
The spectrum of genotoxic effects of ROS and RNS are ranging from nucleobase modification such as 
oxidation (OH*, HOCl), halogenation (HOCl), alkylation, methylation, nitration (N2O3, ONOO
-), 
depurination and deamination, and abasic sites that can be present as isolated tandem or clustered 
lesions. In addition to this, more complex modifications of the DNA structure can also be catalysed 
by these chemical mediators of inflammation (inter- and intra-strand crosslinks, DNA-protein 
crosslinks, single strand breaks (SSB) and double strand breaks (DSB) [8] 60,60-62. In addition, ROS can 
inhibit key proteins of the DNA repair machinery 63. The balance between ROS induced DNA damage 
and repair is responsible for the relatively low level of lesions in normal cells and tissues [9]. 
However, this rate of damage increases with age, chronic diseases or cancer [10] 64,65.  
Isolated oxidative DNA lesions and abasic sites are repaired with relatively high efficiency via base 
excision repair (BER) 66-68, while nucleotide excision repair (NER) removes intrastrand crosslinks 69 
and bulky nucleotide lesions. Mismatched bases and small insertion/deletion loops are repaired by 
mismatch repair (MMR). The pathway choice to repair DSBs depends on the cell cycle state and can 
utilise homologous recombination (HR) or non-homologous end joining (NHEJ). Furthermore, DSBs 
(induced by e.g. -irradiation) are repaired by NHEJ 70,71 and replication-induced DSBs are repaired by 
HR [11] 72. 
1.2.1. Isolated single nucleobase lesions, clustered DNA damage, SSB and DSB 
Inflammation-mediated halogenisation by HOCl or HOBr 73 and nitration by N2O3 
74-79 can damage all 
four nucleotides in vivo giving rise to an abundant variety of nucleobase lesions. From all four 
canonical nucleotides, the most frequently identified oxidised guanine products in vivo are 8-oxodG  
and FapydG (2,6-diamino-4-hydroxy-5-formamidopyrimidine), while the most abundant oxidised 
pyrimidine lesions are thymine glycol (Tg; 5-,6-dihydroxy-5,6dihidrothymidine) and cytosine glycol 
(5-,6-dihydroxy-5,6dihidrocytosine) 1,60,61,80,81. In addition to the above, OH*-mediated hydrolysis of 
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the deoxyribosyl moiety can result in SSBs 82. Abasic sites, inter- and intrastrand G-G/G-A crosslinks 
can arise from nitrosation of purines 74; while oxidised guanines can lead to 8-oxodG:dC or 8-
oxodG:dA pairing, the latter leading to G→T transversions 83 [8].  
Apart from direct nucleotide lesions generated by inflammatory ROS, secondary mutagenic radicals 
(aldehydes, epoxides, lipid hydroperoxides) can also arise from ROS-mediated oxidation of other 
cellular macromolecules and can induce further DNA lesions 84,85. Clustered DNA lesions or non-DSB 
clusters are two or more DNA lesions within one helical DNA turn, which can be either on one strand 
or on both strands of the DNA helix (tandem or bistranded, respectively). Clustered DNA lesions are 
almost exclusively generated by ionizing radiation rather than inflammatory ROS, however, it is also 
reported that single pyrimidine radicals generated by reaction with OH* can attack the 
complementary or neighbouring purine bases 86,87 [8]. 
Typically, non-ionising radiation mediated oxidative stress induces SSBs, while DSBs arise as 
secondary lesions. Incomplete repair of a single lesion by BER (typically a nucleobase lesion or an 
abasic site generated by the AP endonuclease or glycosylase and more frequently by the long-patch 
BER) or by the NER pathways can induce SSBs and two adjacent SSBs (essentially arising from the 
repair of two bistranded clustered lesion) can lead to a DSB 88. When the replication fork collides 
with unrepaired abasic sites or single strand breaks it can results in collapsed replication forks and 
DSBs (replication induced DSB) 72,89. 
1.2.2. mtDNA damage 
The circular mtDNA constitutes 1% of total cellular DNA, is of symbiotic bacterial origin, and 
compared to nuDNA has a very different molecular organisation and regulation. mtDNA has no 
histones and the methylation of CpG repeat motifs is under-represented, therefore it is particularly 
vulnerable to damage by endogenous ROS generated by the oxidative electron transport chain 
during ATP synthesis 90-92. The major nascent mitochondrial ROS molecule is O2*
-, which is quickly 
dismuted to H2O2. Under physiological conditions O2*
- and H2O2 are considered less reactive to 
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mtDNA directly than the OH* radicals generated from H2O2 in the Fenton reaction 
93,94. Due to the 
abundance of the GC-rich repeats e.g. in the ribosomal genes, the most frequent oxidative DNA 
adducts are 8-oxodG 95, however, thymine glycol is also frequent 96,97. Additional mtDNA lesions 
include abasic sites (from OH*-mediated hydrolysis), cytosine alkylation by S-adenosylmethionine 
(SAM) 95, replication-mediated mismatch of modified nucleotides 98 and repair- or replication-
induced SSBs 99 or DSBs 100 [12]. Abundant expression of mitochondrial NO* and secondary radicals 
are also responsible for mtDNA damage.  
The most active pathway in the mitochondria to repair oxidative mtDNA lesions is BER 101. SSBs are 
repaired by the joined BER/SSBR (single strand break repair) pathway 102 while DSBs are by HR, albeit 
at low frequency 103,104, or with NHEJ [13]. mtDNA degradation is another pathway to eliminate 
unrepaired oxidative DNA lesions 93, which is supported by the abundant cellular copy number of 
mtDNA and observations of cellular tolerance to extensive mtDNA loss in vitro 105 106 and in vivo 107 
108,109 [13]. 
2. Oxidised DNA as a pro-inflammatory signal 
Inflammation and ROS-mediated damage modulates the DNA damage response signalling and repair 
pathways resulting in an increase in expression of genes involved in repair and the inflammatory 
response 110. On the other hand, ROS can directly damage or inhibit proteins of these processes as 
well 111,112. In chronic inflammation, persistently high ROS level, reduced repair efficiency and 
dysfunctional mitochondrial respiration can lead to the accumulation of DNA damage 113. If oxidative 
DNA lesions are unrepairable or repair is incomplete, prolonged DNA damage induces permanent 
cell-cycle arrest, senescence, eventually apoptosis or necrosis, during which DNA enters the 
degradation pathway. Under normal physiological circumstances DNA is sequestered in the nucleus 
and the mitochondria away from immune surveillance. Upon apoptosis [14,15] 114 necrosis or tissue 
damage fragmented cellular DNA can enter the vascular circulation and the intracellular space, 
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however, it is not recognised as antigenic for the unchallenged immune system. Failed clearance of 
apoptotic debris, excess circulating extracellular DNA (also known as cell free DNA; ecDNA/cfDNA) 
from necrosis or tissue damage, and increased level of DNA modifications are stimuli for immune 
response and inflammatory pathways, and pathological processes such as atherosclerosis [16], deep 
vein thrombosis [17], thrombotic microangiopathies [18], primary Sjögren’s syndrome or systemic 
lupus erythematosus (SLE) [19] 115. DNA is present in the extracellular milieu (ecDNA) and the 
vascular system of healthy as well as diseased individuals. Increase in its concentration and the level 
of oxidative damage correlates with tissue damage and disease severity. It is important to note that 
normal physiological processes such as ageing, stress and exercise can also lead to increased ecDNA 
levels [20] 116,117. 
There are two sources of circulating ecDNA: 1) virtosomes; newly synthesised 
DNA/RNA/lipopolysaccharide complexes from living cells [21] or 2) cell death; apoptosis, necrosis 
and oncosis [15] 118.  Circulating ecDNA can be taken up by neighbouring or distant cells and could 
act as a messenger to exert biological bystander effect [22] 119.   
The 8-oxodG content of genomic DNA (gDNA) in necrotic cells is enriched and its concentration in 
the ecDNA pool is elevated by oxidative stress or disease [23] 120. Serum from patients with chronic 
diseases contains high levels of cell free oxidamaged DNA [24], while mice treated with antigenic 
oxidised gDNA (gDNAox) show induced inflammation and high anti-DNAox antibody levels [25]. 
Furthermore, similar to oxidised extracellular DNA (ecDNAox) released from damaged cultured cells 
[26] 120, gDNAox generated in vitro [22] is a stress signal and can induce ROS production, causes 
decreased expression, nuclear localisation and transcription of NFB in cultured fibroblasts; DNA 
damage, apoptosis or adaptive response in cells at sites far from the initial oxidative stress. This 
suggests that gDNAox is a potential mediator of bystander effect that is observed following damage 
from both physical (irradiation) and chemical (ROS) sources [22,23,26] 120,121. Low-LET radiation also 
induces ROS-mediated oxidative damage and inflammation in normal non-irradiated tissues [27] 
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122,123.  Naïve cells exposed to either ecDNA from irradiated cells or gDNA extracted from H2O2 
stressed cells show spatial and structural rearrangement of chromosomes within the nucleus, 
facilitating repair and transcription of ribosomal genes and genes involved in repair- and signalling 
processes [28].  
2.2. Oxidised mtDNA as a stress signal 
Circulating mtDNA is passively released to the extracellular space together with other mitochondrial 
macromolecules (e.g. lipids, formyl-peptides) by direct injury to tissue or programmed cell death 
mechanisms 124,125, and is present in measurable amounts with higher 8-oxodG content relative to 
nuDNA [23,29]. The importance of mtDNA in host defence is demonstrated by its active release via 
another immune response mechanism, called neutrophil extracellular traps (NETs): mtDNA and ROS 
are launched by activated eosinophils [30] 126 and neutrophils [31] 127,128 in response to bacterial 
lipopolysacharide  induced IFN- and IL-5 129.  
The immune response to mitochondrial DAMP (e.g.  mtDNA and ROS) is similar to PAMP induced 
PRR signalling and inflammatory immune response.  One might surmise that despite the two billion 
year old symbiosis, mitochondria still possess immunogenic properties reminiscent of bacteria, and 
together with ROS these mitochondrial signals are an additional level in host immune defence (stress 
induced adaptive response) to maintain or restore homeostasis or if it is beyond that induce cell 
death. This may not be too far-fetched from the bacterial SOS response to ROS-induced damage 
from host cells. Invading bacteria activate pathogen recognition receptors, incite chronic 
inflammation and host DNA damage to hijack host DNA repair processes in order to repair their own 
DNA and gain bacterial resistance and survival.  However, prolonged inflammation inhibits DNA 
repair, eventually leading to cancer. Helicobacter pylori infection downregulates MMR and BER and 
consequently induces carcinogenesis [32] 130-132, especially if H. pylori infection is associated with 
underlying metabolic syndromes such as diabetes or obesity [33] 133. Exposure of cultured MEFs and 
HCT116 cells to oxidative stress showes much higher frequency of SSBs, but only a marginal increase 
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of 8-oxodG load in mtDNA [34]. On the other hand 8-oxodG level is increased in the fragmented 
mtDNA population in tissues [23,29], which implicates that if repair is overwhelmed mtDNA 
degradation is a potential pathway to maintain mitochondrial genomic integrity by clearing out 
damaged copies. Released extracellular or intracellular oxidamaged mtDNA (mtDNAox) fragments 
than act as mediators of immune response via DAMP activated TLR9 receptor signalling (see below). 
A large body of in vitro and in vivo data supports that 8-oxodG DNA fragments with high GC content 
promote local as well as distant inflammation. Exposure of cultured murine macrophages to such 
DNA induces TNF secretion [35], while bystander effect has been demonstrated in a murine model: 
when the liver was injected with isolated mtDNA it also induced lung inflammation [36]. mtDNA 
binding to TLR9, subsequent p38MAPK phosphorylation and IL-8 secretion are diminished in vivo in 
cultured neutrophils that are incubated with oligonucleotides complementary to CpG repeats of 
mtDNA  [36]. Bacterial-like non-methylated CpG rich mtDNA, therefore, can influence inflammation 
that is found to  increase lung injury and arthritis in murine models in vivo, which is further 
enhanced by oxidative mtDNA damage [36,37]. Furthermore, cell free oxidised mtDNA is found in 
arthritic joint fluids [37] 134. 
Oxidative stress induces elevated mitochondrial respiration and translocation of thioredoxin-
interacting protein (TXNIP) from the nucleus to the mitochondria [38]. In the mitochondria TXNIP 
inhibits the antioxidant thioredoxin 2 (TRX2) [39], which leads to mtDNA damage, elevated ATP 
synthesis, amplified ROS production and dysfunctional mitochondria to culminate in inflammation or 
cell death 135-137 [40]. A genuine cellular response to eliminate dysfunctional mitochondria is 
mitophagy (mitochondrial autophagy) 138, which blocks NLRP3 inflammasome activation and the 
inflammatory response [2,41]. NLRP3 (NLR family, pyrin domain containing 3) is a molecular monitor 
of the metabolic status of mitochondria and the cytosol for DAMPs and PAMPs [42] 20 e.g. various 
radiation-generated ROS [43], asbestos and silica [44], -amyloid plaques [45], extracellular ATP [46], 
oxidised mtDNA [47] and double-stranded RNA [48]. Depletion of mtDNA also inhibits 
inflammasome activation [41]. In the absence of mitophagy, augmented ROS can activate the 
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opening of mitochondrial permeability transition pores (mPTP) and the release of cytochrome c, ATP 
and Ca2+ to the cytosol. This in turn induces the intrinsic (mitochondrial) apoptotic pathway through 
the activation of the apoptosome 138,139 and a subsequent release of ROS, TXNIP, non-oxidised and 8-
oxodG rich oxidised mtDNA to the cytosol, which then directly bind to NLRP3 [2,41,47] 18,140. Priming 
of the NLRP3 inflammasome requires a pro-inflammatory signal likely provided by ROS 141. 
Oxidamaged mtDNA binds to the pyrine domain of NLRP3, which then interacts with the cytosolic 
apoptosis-associated spec-like protein (ASC) component and induces the assembly and activation of 
the NLRP3-ASC adaptor-procaspase-1 complex (inflammasome). The active NLRP3 inflammasome 
relocates from the ER to the perinuclear space and binds to the mitochondrial outer membranes via 
the mitochondria-associated adaptor molecule, MAVS (mitochondrial antiviral signalling) [2] 142. 
Mitochondrial membrane-bound NLRP3 instigates inflammatory caspase-1 autocatalysis 143, which 
interlinks pathways of cell death and the inflammatory response 139 (Fig. 1A). Active caspase-1 
enhances proteolytic cleavage and secretion of pro-inflammatory cytokines (IL-1 IL-33 and IL-18) 
[42] 144,145, which in turn result in the expression of TNF and IFN (α/β and  instigating further 
immune cell recruitment. These pro-inflammatory cytokines activate the IL-1 or TNF receptors, and 
downstream NFB signalling 146. Activated caspase-1 also instigates the pyroptosis pathway: an 
inflammatory form of apoptosis characterised by cellular ‘rapture’ that releases its pro-inflammatory 
content, including oxidised DNA fragments 124,147. NLRs are also involved in and regulate mtDNA-
mediated inflammation and apoptosis in concert with TLR9 [47,49].  
Recent in vivo and in vitro studies show that intact or oxidised mtDNA is a danger signal [1] 129,148, 
and induces pro-inflammatory cytokine (TNF IL-6 and IL-10) expression. This in turn promotes 
recruitment of activated macrophages, age related low level inflammation [20], or sepsis-like non 
infection associated, sterile SIRS (systemic inflammatory response syndrome) via the DAMP 
activated TLR9/NFB pathway following trauma and lung injury [50]. However, other DNA sensors 
are likely involved in mtDNA and ROS mediated damage signalling [26] 120 as well.  
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In vivo and in vitro studies show that the effect of mtDNA as a damage signal is much more adverse 
than that of nuDNA [1] 148,149. As protein coding in mtDNA is restricted to elements of the electron 
transport chain, many functions (replication, repair and transcription) in mitochondria rely on 
products encoded in the nuclei that are transported to the mitochondria 150,151. As a consequence, 
nuDNA damage is also an important contributing factor to dysfunctional mitochondria 152. 
3. Transduction of damaged DNA induced stress signal  
Several different proteins have been identified to date (including MRE11 153, PARP-1, Ku70, DNA-PK 
154 IFI16 155, DDX41 156, RNA Pol-III 157, cGAS 158, DAI, HMGB1, AIM2 159, RIG-1, TLR9 and STING 160-162) 
[51] 163, which bind pathogen- or host derived DNA (originating from either the mitochondria or 
nuclei in response to cellular stress) and initiate defensive immune-response via NLRs, TLRs or RLRs 
(retinoic acid inducible gene-1 [RIG-1]-like receptors) mostly in a cell-type specific fashion. These 
sensors bind dsDNA in a non-differentiating manner only showing some preferences to non-oxidised 
or 8-oxodG rich DNA structures [47]. Further investigations are required to identify a specific DNA 
structure for pathogen derived DNA PAMPs 164 or conditions and conformations (emerged from its 
processing) that designate host-derived DNA 165 as DAMPs. 
3.1 TLR9 
Toll-like receptor 9 (TLR9) is present in cellular, nuclear and phagosomal membranes of innate 
immune cells and its expression is elevated during inflammation and starvation [22]. Non-
methylated bacterial CpG-DNA from phagocytosis and mtDNA with the same properties are ligand to 
TLR9 via the extracellular high mobility group protein-1 (HMGB1). 8-oxodG enriched ecDNAox from 
tissue damage, cell death (pyroptosis) or mitochondrial release as DAMPs are preferred TLR9 ligands 
[52] 166,167, while extracellular histones are direct TLR9 ligands [53]. Ligand activation followed by the 
binding of the signalling adaptor MYD88 to TLR9 168,169 induces TLR9 translocation from the ER to the 
endosomes [54]. MYD88 is also a signalling adaptor of the cytokine receptor IL-1R [55] linking the 
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TLR-dependent and TLR-independent inflammatory response pathways. The downstream effect of 
TLR9/MYD88 stimulation leads to IB degradation and nuclear translocation of the NFB 
transcription factor and the simultaneous phosphorylation of p38MAPK. This subsequently induces 
the synthesis and release of IFN- and TNF. NFB, in combination with other transcription factors 
e.g. AP-1, IRFs and CREB, induces the expression of proteins like additional pro-inflammatory 
cytokines (IL-1 IL-6, IL-10, IL-18), NOX2, NLRP3, TRX2, TRX3 to regulate innate (monocyte 
recruitment) and adaptive (T- and B cell activation) immune response, local inflammation [36,50] 
170,171, inflammation in distant cells or organs (bystander effect) [36] and senescence, as well as 
proliferation, tissue repair and survival [49] 172-176 (Fig. 1B). 
Accumulation of non-degraded mtDNA leaking from overwhelmed autophagy induces TLR9 
expression and TLR9-mediated inflammation [56]. Similarly, ecDNA from cancer patients induces 
TLR9 expression in mesenchymal stem cells [26], while TLR9 inhibitors decrease damaged ecDNA 
induced TLR9-mediated DNA damage response (chromosome remodelling, nuclear rearrangement, 
rRNA expression) in the bystander cells [22]. 
3.2 AIM2 
Similar to phagolysosomal pathogen entry to the cytosol, intracellular dsDNA and mtDNA can bind 
and activate another type of inflammasome, AIM2 (Absent in melanoma-2) and induce caspase-1 
mediated activation and secretion of IL-1 and IL-18 in addition to caspase-1 induced pyroptosis [57] 
177,178 (Fig. 1A). Rathinam and co-workers also showed that cytosolic dsDNA induces type I IFN and 
AIM2 expression. This suggests that oxidised ecDNA that escapes degradation following entry into 
the cell via phagosomes can induce cell death and inflammation. However, in macrophages, non-
oxidised DNA preferentially activates AIM2 [57], while oxidised mtDNA induces NLRP3 
inflammasome assembly and both induce IL-1 secretion [47]. 
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3.3 STING 
The presence of 8-oxodG lesions alleviates the susceptibility of DNA to degradation by the TREX1 
exonuclease [58], and as a consequence it accumulates to induce immune response. Elevated ecDNA 
level from increased apoptosis or NETs from dying neutrophils with defect in lysosomal DNase 
activity are characteristic for SLE [59].  Elevated ROS production induces NET formation 179, hence 
ecDNA in SLE accumulates 8-oxodG lesions that are sensed by STING (stimulator of IFN genes) and 
induces IRF signalling [58]. Following dsDNA stimuli STING relocates from the ER membrane to 
perinuclear endosomal compartments and forms a complex with TANK-binding kinase 1 (TBK1) [60] 
(Fig. 1C). The STING-TBK1 complex activates IKK to induce the NFB or IRF3 pathways in a TLR-
independent manner and induces Type I IFN expression and release, thus overstimulation of anti-
viral and inflammatory innate immune responses via membrane IFN-receptor (IFNAR) in 
neighbouring cells and lymphocytes. Type I IFN-mediated receptor activation initiates the Janus 
kinase (JAK) signal transducer and the STAT (signal transducer and activator of transcription) 
pathway stimulating the expression of different antiviral genes 180,181. 
dsDNA also activates translocation of STING to the apoptosome where it associates with TBK1 and 
interacts with autophagy-related proteins (Atg-9a) promoting autophagy [61]. Although STING-
dependent IFN- production is proven to be stimulated by synthetic poly(dG:dC) and dsDNA in 
MEFs, binding and colocalisation of STING to DNA were not shown suggesting that STING is not a 
DNA binding protein [60]. However, Abe and co-workers shown low affinity dsDNA binding to STING 
homodimers [62]. Upstream dsDNA binding molecules that induce the STING-TBK1-IRF3 pathway are 
IFN-inducible protein 16 (IFI16) [63] and DEAD-box polypeptide 41 (DDX41) [64], in addition to the 
recently identified cyclic GMP-AMP (cGAMP) synthase (cGAS) (Fig. 1C). cGAS binds and activates 
STING via the secondary messenger cGAMP and triggers NFB and IFN response [65] 182,183. The 
bacterial cyclic di-adenylate monophosphate (c-di-AMP) and cyclic di-guanylate monophosphate (c-
di-GMP) are directly sensed by STING [66] 184,185 as well as via DDX41 [67]. The reduced IFN- level in 
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Sting-/- MEFs to synthetic poly(dA:dT) dsDNA was accounted for an additional Type I IFN response 
that is independent of both TLR and STING, and mediated by the dsDNA induced innate immune 
signalling receptor  RIG-1 [60].  RIG-1, a member of the RLR family, is a dsRNA receptor that also 
triggers antiviral response to dsDNA 186-188. 
3.4. DNA damage sensor and repair proteins in inflammatory immune 
response 
Damage to the DNA induces a cascade of actions commonly termed the DNA damage response 
(DDR). DDR includes the activation of different transcription programs, cell cycle checkpoints to 
induce transient or permanent cell cycle arrest (senescence), activation of specific repair pathways 
and apoptosis if repair fails. While the dsDNA-mediated immune-response pathways have been well 
characterised, there are still new alliances being discovered between DNA damage sensors of the 
DNA repair pathways and DNA receptors of the immune system. 
3.4.1. MRE11 
The MRN complex, consisting of MRE11 (Meiotic recombination 11 homolog A), RAD50 and NBS1 
(Nijmegen breakage syndrome 1), is one of the first proteins to sense and bind broken double-
stranded DNA ends. MRE11 possesses 3’→5’ exonuclease activity and contributes to the resection of 
the broken end thus facilitates and regulates HR or NHEJ depending on cell cycle 71,189. The complex 
controls DDR via the CDK phosporylation-dependent binding of CtIP to NBS1 and facilitating the ATM 
dependent phosphorylation of CtIP 190-192.  Once activated, CtIP promotes end resection by 
stimulating the endonuclease activity of MRE11 in an S-phase dependent manner [68] (Fig. 1D). In 
addition to IFI16 and DDX41 dsDNA binding proteins, MRE11 was also implicated in stimulating 
dsDNA induced type I IFN mediated inflammatory signalling via the STING-dependent pathway [69]. 
It has been shown in MEFs and ataxia telangiectasia-like disorder (ATLD) cells treated with non-AT-
rich IFN stimulating DNA sequences, that MRE11 in complex with RAD50 but independent from 
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NBS1, induces IFN-expression, and activation and translocation of STING. MRE11-mediated STING 
activation is not induced by pathogen-derived DNA suggesting that MRE11 rather functions in host 
damage response [69] (Fig. 1C). ATM activation promoted by MRE11 ultimately induces the p53 and 
p21 checkpoint proteins and cell cycle arrest, indicating a role of MRE11 in the control of p53 
dependent apoptosis and cell-cycle regulation, and a direct link between DDR and the immune 
response pathways 193. While p53 is considered to be a tumour suppressor, when overexpressed or 
in constant activation it can promote pro-tumorigenic inflammation 194. Yan et al reported that in rat 
liver constant genotoxic stress-induced persistent DNA damage sustained elevated p53 expression 
and subsequently increased HMGB1 secretion, pro-tumorigenic hepatic inflammation and apoptotic 
hepatic injury in wild type rats, which was less severe in heterozygous p53+/- rats [70] 195. 
Additionally, ATM also induces a pro-survival response via activated NFB, which in turn accelerates 
DNA end resection, promotes HR, and induces BRCA2 and ATM transcription [71] (Fig. 1D). 
3.4.2. PARP-1 
Persistent unrepaired DNA lesions can cause replication fork stalling. A stalled replication fork may 
collapse if it is processed by endonucleases like MUS81, or if a progressing fork encounters an SSB it 
is converted to a DSB 196. Stalled replication forks can reverse to aid template switching, replication 
past a lesion and replication restart. Collapsed forks can be re-built and replication reinstated 
through the homologous recombination repair pathway 197,198. This process is initiated with end-
resection that is catalysed by the MRN complex. Stalled replication forks, SSBs, DSBs, DNA cross over 
or stem loop/cruciform structures are sensed by the DNA binding and scaffold protein poly-ADP-
ribose polymerase (PARP-1) [72]. PARP-1 has a bipolar effect in oxidative stress-induced DDR: DNA 
repair and survival or necrotic cell death. PARP-1 directly binds and recruits several proteins of the 
major repair pathways (MRE11, NBS1 199,200, Ku70 201, DNA-PK 202, ATM 203) and regulates chromatin 
remodelling, DNA replication and repair, and transcriptional activity of inflammatory factors 204-206 
(Fig. 1F). PARP-1 is also involved in caspase-1 mediated [73] or caspase-independent [74] apoptosis 
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and autophagy 207 [75]. PARP-1 catalyses the addition of poly (ADP-ribose) (PAR) chains to its 
substrate proteins and facilitates DNA repair. Persistent DNA damage induced PARP-1 over-
activation results in the depletion of cellular NAD+. NAD+ re-synthesis leads to the depletion of 
cellular ATP reserves, impaired energy metabolism, cellular and mitochondrial dysfunction and 
necrosis; known as PARP-suicide [76]. PARP-1 is implicated in many inflammatory diseases including 
diabetes 208, asthma 209,210, atherosclerosis 211 and hepatic fibrosis 212 [77]. PARP-1 directly interacts 
and activates (PARylation) p53, and NFB [78] 213,214, while interaction with p21 inhibits PARylation 
activity [72] 215. In addition, PARP-1 was shown to regulate the phosphorylation of ERK1/2, 
p38MAPK, and c-Jun [78]. Similar to senescence, DNA damage induced PARP-1 over-activation 
generates an inflammatory feedback loop. PARP-1 binding to NFB induces NFB-mediated 
inflammatory immune-response by iNOS and expression of pro-inflammatory cytokines (e.g. IL-1, 
TNF leading to inflammatory ROS production and persistent DNA damage [72] 216-219. 
3.4.3. Ku70 and DNA-PK 
DSB is sensed by Ku70 to facilitate the Ku-dependent non-homologous DNA end-joining pathway 
(NHEJ), the major cell-cycle independent repair pathway of double stranded DNA breaks 70. Ku70 is 
also implicated in the triggering of inflammatory signalling by inducing IRF1 and IRF7-mediated Type 
III IFN expression (IFN-1) [79] (Fig. 1E). 
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a member of the phosphatidyl-inositol 
(PI3) kinase family (of which ATM and ATR are also members). DNA-PKcs is activated upon binding to 
the Ku70/Ku80 regulatory subunit bound to dsDNA ends. DNA-PK plays a central role in DNA repair 
(NHEJ) and in V(D)J recombination of programmed DNA rearrangements in lymphocyte 
differentiation in the nucleus 70,220,221, but it also plays a role in the cytoplasm [80] 222,223.  
Macrophages expressing catalytic dead DNA-PKcs or siRNA knock down of DNA-PKcs showed that its 
activity is essential for transfected synthetic CpG oligonucleotide -induced expression of the anti-
inflammatory cytokine IL-10 while DNA-PKcs activity inhibits the expression of the inflammatory 
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cytokine IL-12p70. It correlates with  previous findings that unmethylated CpG oligonucleotides 
induce IL-6, IL-10, IL-12, type I IFN and TNFin dendritic cells (DC), macrophages and B cells [81] 224. 
DNA-PKcs-mediated cytosolic binding of CpG oligonucleotides is a pre-requisite for the regulation of 
IL-12p70 and IL-10 expression through the DNA-PKcs-ERK mediated pathway. Interestingly, the CpG 
oligonucleotide-liposome complex also induces IL-12p70 [80]. Nevertheless, IL-12p70 induction 
could also be a response of TLR4 receptor activation that is probably induced by the liposome itself.  
A recently described cytoplasmic function of DNA-PK is the cytoplasmic DNA-mediated activation of 
IRF-3 in vitro and in vivo via STING-TBK1 stimulation (Fig. 1C). DNA-PKcs directly binds cytoplasmic 
DNA, which is enhanced by Ku and DNA-PKcs catalytic activity is not required for IRF-3 signalling [82]. 
3.4.4. HMGB1 
HMGB1 (also called alarmin) is a chromosomal scaffold protein with diverse nuclear, cytosolic and 
extracellular functions. In the nucleus it facilitates chromatin assembly, binding of protein-
complexes, and regulates transcription 225, replication 226, chromatin remodelling upon DNA damage 
227,228 and DNA repair. HMGB1 can bind to different DNA structures in vivo and promote the NER 229, 
BER 230,231 and MMR 232 pathways. HMGB1 enhances the binding and the activity of Ku and DNA-PK 
at the DSB ends in NHEJ 233 and is implicated in V(D)J recombination 234 [83]. In addition to 
recognising specific DNA structures: supercoiled, hemicatenated, single stranded, B- and Z-DNA, 
four-way junction, triplex DNA, looped structures and DNA mini circles [83] 166,235, HMGB1 has strong 
binding affinity to damaged DNA sequences like UV treated oxidised DNA [84] and to CpG DNA. 
HMGB1 promotes TLR9 translocation to the endosomes and the HMGB1-CpG DNA complex induces 
TLR9 mediated IL-6, IL-12 and TNFα secretion in macrophages and DCs [85] (Fig. 1B). In response to 
starvation induced mitochondrial ROS mediated oxidative stress, HMGB1 actively translocates to the 
cytosol to inhibit apoptosis and to promote autophagy and survival. Intriguingly, this process is 
hijacked by tumour cells by overexpressing HMGB1 [86] 236. As an extracellular DAMP, it induces pro-
inflammatory signalling when released by activated immune cells [87] 237,238 or necrotic non-immune 
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cells [88] 239. It acts as a cytokine: stimulates migration of immune cells in complex with CXCL12 [89], 
secretion of pro-inflammatory TNF IL-1 and IL-6 240, and induces secondary delayed inflammatory 
response [90].  HMGB1 signals through the cell surface RAGE receptor on immune and non-immune 
cells to activate NFB  via the Ras-MAPK pathway [91], to promote tumour invasion by activating 
MAP kinases p38MAPK, JNKs and ERK1/2 (p44/42 MAPK) [92], and to induce NET formation via 
TLR4-mediated signalling [93]. Thus, HMGB1 is a contributing factor to many pathogenic conditions 
including sterile inflammations [94], sepsis [95] 241; chronic inflammatory diseases like rheumatoid 
arthritis [96]; autoimmune diseases like SLE [97] and tumour development and survival [98] 236,242. As 
a specific example: in chronic lymphocytic leukemia (CLL) plasma HMGB1 endorses proliferation of 
the nurse-like cells and the tumour via the RAGE-TLR9 pathway [99]. These suggest that in addition 
to its active release by activated innate immune cells to mediate pathogenic PAMP (GpC DNA) 
activated inflammatory immune response, nuclear HMGB-1 maintains DNA repair, genome integrity 
and promotes survival. Once DNA damage becomes prolonged and repair fails DNA-HMGB1 
structures are released by necrosis and as DAMPs induce a second wave of inflammatory response 
that can be hijacked by tumour cells. 
4. Concluding remarks 
The link between DNA mutations, genome instability and tumour development is well established, 
and it is also widely recognised that chronic inflammation is a cancer susceptibility factor. 
Understanding the interplay between DNA damage response pathways and inflammation has 
dominated research in recent years. Our understanding of how the genotoxic effects of 
inflammation induce DNA damage response, and how factors of the DDR pathway and the PRR-
mediated inflammatory immune response processes interlink to maintain homeostasis have 
advanced significantly. It all supports the hypothesis of a global inflammation cascade propelled by 
ROS and DNA damage. Loss of immune homeostasis and prolonged acute inflammation generated 
by different sources (infection, radiation, toxins, autoimmune disease and genetic susceptibility to 
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inflammation, aging, dietary factors and many more) induce ROS production, elevated ROS-
mediated oxidative DNA damage, reduced repair capacity launching more ROS and oxidamaged DNA 
(nuclear and mitochondrial) by death of damaged cells. This in turn induces secondary and 
subsequent inflammation in intact distant bystander cells as stress signals, which accelerates into a 
systemic acute inflammation or cancer. The balance between these counteracting pathways is 
delicate and aim to avoid chronic inflammation, loss of genomic integrity by promoting DNA repair, 
or induce apoptosis to eliminate cells with accumulated unrepaired pro-tumorigenic mutations.  
Amongst many regulatory factors, damaged DNA within the nucleus and the mitochondria, or 
released from dying cells seems to play a central role by signalling danger and influencing repair and 
inflammation-associated pathways. Hence, while developing targeted therapeutic approaches to 
treat inflammation-associated diseases, the complex relationship between DDR and inflammatory 
immune processes has to be taken into consideration. 
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Figure legends 
Figure 1. Complex relationship between the inflammatory and DNA damage (DDR) response 
pathways. Genotoxic ROS induced DNA damage is sensed at different levels during inflammation 
and is a contributing factor to the pro- and anti-inflammatory immune response to restore tissue 
homeostasis. The cytosolic dsDNA sensor (A) AIM2 and NLRP3 inflammasomes contribute via ligand 
activated caspase-1 to the inflammatory catabolic NFB pathway by post-translational cytokine 
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activation, or if the damage is greater induce cell death programmes. (B) Other cytosolic DNA 
sensors (IFI16, DDX41, DNA-PK etc.) via activated STING-TBK1 integrate into the cytokine and 
interferon signalling pathways in a TLR- independent manner promoting pro-inflammatory innate 
immune processes. (C) The same response is instigated by dsDNA in different endosomal 
compartments via the membrane bound TLR9 receptor. Nuclear damaged DNA sensors induce the 
DDR response: (D) the MRN complex (MRE11-RAD50-NBS1) through activated ATM and (F) PARP-1 
instigate cell cycle arrest via the p53-p21 axis, DNA repair processes and additional transcriptional 
activation of inflammatory and repair genes (Pro-ILs, Type I IFN, NLRP3, ATM etc.) via NFB or (E) via 
IRF3 transduced from the Ku70/Ku80/DNA-PK complex to promote cell survival or cell death in case 
of persistent damage.  
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